Mike Kreitzinger

SVP Global Business Development

Mike Kreitzinger has served as Biocartis’ Senior Vice President of Global Business Development since 18 August 2025. With a career spanning more than 25 years in clinical diagnostics, Mr. Kreitzinger brings a unique blend of business strategy, clinical diagnostic sales, and commercial leadership expertise to Biocartis. Most recently, he served as Senior Director of Clinical Strategy and Partnerships at Illumina, where he led the development and implementation of comprehensive strategic clinical plans to bring next-generation sequencing closer to the patient and aligned partnerships to accelerate adoption of genomics in the clinic. Prior to that, Mr. Kreitzinger held various senior commercial leadership roles at Illumina and led US sales at other companies, including Cepheid (a Danaher company) and Alere, now part of Abbott Diagnostics. Mr. Kreitzinger holds an MBA from Florida Gulf Coast University and Bachelor of Arts degree from Florida State University.

Roger Moody

Chief Executive Officer

More than 30 years of experience in the life science and medical technology market, experienced in scaling up public and private companies.

Randy Polonsky

Chief Financial Officer

Seasoned executive with 15+ years of experience in financial planning and analysis, corporate development, operational excellence, and leadership across both public and private equity global companies.

Bria Mertens

General Counsel

Seasoned healthcare and life sciences attorney with almost 20 years of experience across diagnostics, biotech, and precision medicine.

W. Michael Korn, MD

Chief Medical and Scientific Officer

Renowned Molecular and Gastrointestinal Oncologist with extensive experience in the development and implementation of precision oncology strategies.

Sarah Baudenelle

Chief Manufacturing Officer

Senior operations leader with 15+ years of dedicated experience in operations management. Excels in optimizing processes, streamlining efficiencies, and ensuring seamless operations in diagnostics and pharma.

Susy Spruyt

Chief People Officer

Accomplished leader with 20+ years of experience in human resources and organizational development. Keen ability to foster a culture of growth, innovation, talent management and employee well-being.

David Dejans

Chief Commercial Officer

Accomplished leader with almost 20 years of experience in managing commercial organizations in the field of molecular biology and immuno-assays.

Anthony Green

EVP Corporate & Business Development

Seasoned corporate and business development leader with 20+ years of experience advancing oncology diagnostics and molecular testing through strategic partnerships and global commercial execution.

Bart Penninger

SVP R&D

Experienced R&D leader with 20 years of experience, combining a background in engineering, innovation, and operational excellence.

Ben Svarczkopf

SVP Global Marketing

Accomplished leader with 25+ years of experience in clinical lab science, offering a unique blend of business acumen, clinical knowledge, and extensive biotechnology expertise.

Mike Kreitzinger

SVP Global Business Development

Accomplished leader with 25+ years of experience in clinical diagnostics, bringing a unique blend of business strategy, clinical diagnostic sales, and commercial leadership expertise.

Emily Korkofigas

SVP Business Transformation

Transformational leader with 20 years of experience in medical devices, recognized for guiding organizational change, executing strategic priorities, and driving excellence in regulated environments.

Jeremiah Gerdin

VP US Commercial

Transformational commercial executive with 15 years of experience in molecular and oncology diagnostics, known for driving strategic growth, building high-performing teams, and executing market expansion.